A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of two
formulations of the Latanoprost-PPDS in subjects with ocular hypertension or open-angle
glaucoma.